CS
OCGN icon

Credit Suisse’s Ocugen OCGN Stock Holding History

Credit Suisse’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-68,000
Closed -$58K – 3229
2023
Q1 		$58K Sell
68,000
-154,052
-69% -$168K ﹤0.01% 3232
2022
Q4 		$289K Sell
222,052
-19,804
-8% -$30.9K ﹤0.01% 3061
2022
Q3 		$430K Buy
241,856
+76,775
+47% +$191K ﹤0.01% 2873
2022
Q2 		$375K Buy
165,081
+724
+0.4% +$1.73K ﹤0.01% 3030
2022
Q1 		$541K Buy
164,357
+9,101
+6% +$32K ﹤0.01% 2928
2021
Q4 		$707K Buy
155,256
+26,138
+20% +$197K ﹤0.01% 3580
2021
Q3 		$928K Buy
129,118
+13,527
+12% +$99.3K ﹤0.01% 3401
2021
Q2 		$928K Buy
115,591
+94,366
+445% +$796K ﹤0.01% 3445
2021
Q1 		$144K Buy
+21,225
New +$141K ﹤0.01% 4164
2019
Q3 		– Sell
-4,038
Closed -$46K – 4213
2019
Q2 		$46K Hold
4,038
– – ﹤0.01% 4003
2019
Q1 		$28K Hold
4,038
– – ﹤0.01% 3928
2018
Q4 		$21K Buy
+4,038
New +$129K ﹤0.01% 3833

Other funds holding OCGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Credit Suisse's OCGN Position: Q2 2023 in Review

Credit Suisse sold out of Ocugen (OCGN) in Q2 2023, closing a stake of 68,000 shares — an estimated $58K sold.

Credit Suisse first reported a position in OCGN in Q4 2018 and held it in 12 quarters. The position peaked at $928K in Q3 2021. 96 funds tracked by Wall St. Rank hold OCGN as of Q2 2023.

  • Credit Suisse reported no remaining Ocugen position as of Q2 2023 after selling out during the quarter.
  • Credit Suisse sold 68,000 Ocugen shares in Q2 2023, an estimated $58K.
  • Credit Suisse first reported a position in Ocugen in Q4 2018 and held it in 12 quarters.
  • Credit Suisse's Ocugen position peaked at $928K in Q3 2021.
  • 96 funds tracked by Wall St. Rank held Ocugen as of Q2 2023.

Based on Credit Suisse's 13F filing for Q2 2023, filed 11 Aug 2023.